Dr. Nick Gravenstein and Cyndi Garvan, PhD with the University of Florida present the use of adenosine for the treatment of ARDS caused by COVID-19. Led by Dr. Bruce Spiess, the “Arctic Team at University of Florida investigates adenosine, a ubiquitous molecule with all kinds of important impacts. It actually can interfere with some viral entry into cells. Normally it’s used to treat cardiac arrhythmias (intravenously) but the team from Florida think there could be a potential COVID-19 repurpose use case for the already approved drug. For example it has shown antiviral qualities. Watch the event sponsored by Steve Kirsch and the COVID-19 Early Treatment Fund (CETF).